Featured Research

from universities, journals, and other organizations

Interleukin-10 may be prognostic factor in treatment with autologous melanoma vaccine

Date:
June 7, 2010
Source:
Thomas Jefferson University
Summary:
Scientists from the Kimmel Cancer Center at Jefferson have found that interleukin-10 production in tumor cells is a possible prognostic factor in patients with advanced melanoma who are treated with autologous melanoma cell vaccine.

Scientists from the Kimmel Cancer Center at Jefferson have found that interleukin-10 production in tumor cells is a possible prognostic factor in patients with advanced melanoma who are treated with autologous melanoma cell vaccine.

They are presenting their data at the 2010 ASCO Annual Meeting in Chicago (Abstract #8588).

"High production of interleukin-10 (IL-10) in the tumor cells was associated with worse prognosis after patients receive the vaccine," said Amit Mahipal, M.D., a fellow in Hematology/Oncology at Jefferson Medical College of Thomas Jefferson University, and lead author of the study. "Because it downregulates the T cell-mediated immune response, high IL-10 levels in the tumor microenvironment may decrease the effectiveness of the vaccine."

An autologous cancer vaccine is a treatment created from a patient's own tumor cells. When the vaccine is administered to the patient, it may elicit an immune response and kill the tumor cells. IL-10 is a cytokine that plays a major role in adjusting the degree of immune response. It has previously been shown that high IL-10 levels in the blood indicate progression of metastatic melanoma.

In the study, led by Takami Sato, M.D., professor of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, the researchers evaluated 44 patients with stage III and stage IV melanoma. Tumor cells were extracted from melanoma tissues and preserved for vaccine production. Prior to vaccine production, the researchers separated a small portion of melanoma cells from the tissues. These small portions were then cultured for the production of IL-10. The tumor specimens were used for autologous cancer cell vaccine after modification with a chemical called dinitrophenyl (DNP), which makes tumor cells more foreign to the host immune system.

Overall, the median overall survival for high IL-10 producers was 10.5 months vs. 42 months for low IL-10 producers. The difference in median overall survival was more striking in patients with stage III disease: 9.7 months for high IL-10 producers vs. 84 months for low producers. For stage IV disease, the overall survival for high IL-10 producers was 10.5 months vs. 13.7 months for low producers.

"We think that the vaccine treatment may be more effective if you combine the cancer vaccine with a blockade of IL-10," Dr. Mahipal said.

A specific blockade for IL-10 was already developed and is under investigation by Dr. Sato's group at Thomas Jefferson University.


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "Interleukin-10 may be prognostic factor in treatment with autologous melanoma vaccine." ScienceDaily. ScienceDaily, 7 June 2010. <www.sciencedaily.com/releases/2010/06/100607101804.htm>.
Thomas Jefferson University. (2010, June 7). Interleukin-10 may be prognostic factor in treatment with autologous melanoma vaccine. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2010/06/100607101804.htm
Thomas Jefferson University. "Interleukin-10 may be prognostic factor in treatment with autologous melanoma vaccine." ScienceDaily. www.sciencedaily.com/releases/2010/06/100607101804.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins